XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01412294
Recruitment Status : Active, not recruiting
First Posted : August 9, 2011
Last Update Posted : July 27, 2017
Information provided by (Responsible Party):
Epidemiological and Clinical Research Information Network